ImmunologybioRxivPreprint
Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
J. Logue, R. Johnson, N. Patel…·M. Frieman
This study evaluates a nanoparticle vaccine against SARS-CoV-2 variants, showing it induces strong immune responses and protection in mice and baboons against multiple variants.
DOI 10.1101/2021.06.08.447631